PATENT CLAIM ANALYSIS

Application Number: 15762118
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-05
Patent Classification: ["424", "001730"]

Abstract:
Amine modified dextran is labeled with mannose molecules as well as tin-117m. This tin-117m labeled mannose modified dextran is useful in treating maladies that express CD206, in particular rheumatoid arthritis, as well as the cancer typically located in the lymph nodes. This provides a systemic treatment for such maladies. The tin-117m will destroy cells to which it is bonded and also can be imaged. Further, due to the nature of the radiation from the tin-117m, it does not do significant damage to nearby healthy cells.

Claim (Index 6):
The method claimed in  claim 1  wherein said effective dosage is a hormetic dosage.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 90.0
- Lexical Diversity: 1.51613
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14891835', '15280062', '14082293', '13592836', '14367758']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.649706531039962
- 35 USC 102 Novelty (BERT): 0.5260034687845953
- Combined Prediction Score: 0.6373362248144253
- Mean Citation Score: 117.2687212
- Max Citation Score: 132.31993
- Similarity Product: 60.15246356230975

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test